Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
Subsequent check-ins occur every 46 weeks, allowing us to fine-tune the regimen and monitor progress
Phase 2 trial data confirm that diarrhoea is among the most frequently reported side effects, particularly during dose escalation
The treatment Understanding the treatment Active Ingredient: Semaglutide Wegovy is a once-weekly injectable GLP-1 receptor agonist that mimics a natural gut hormone to reduce appetite and slow stomach emptying
Its your job to know the rules
This is known as delayed gastric emptying, and can lead to food remaining in the stomach for much longer than usual
Run the initial retatrutide starting dose of 1 mg weekly for the first four weeks
US$ 28.73
US$ 26.26
US$ 26.50
US$ 23.94
US$ 22.30
